Avenue Therapeutics reports second quarter 2017 financial results
Avenue Therapeutics reported the net loss was $2.4 million, or $0.70 per share, for the 2017 second quarter versus a net loss of $0.8 million, or $0.28 per share, for the same 2016 period. As of June 30, 2017, Avenue's cash totaled $34.7 million. August 11, 2017